The idea is alluring: Get a computer to read electronic pathology reports and automatically flag aberrations in tumor DNA that indicate a patient’s increased receptivity to a specific type of cancer therapy.
A confluence of technological advances is now making this possible, as artificial intelligence gives doctors the ability to quickly comb massive genomic data sets for clues on how to personalize treatment.
About the Author Reprints
